Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 05, 2018
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 19, 2017
Showing 1-2 of 2
Last Updated: 09/26/2026